Funding news
Moxie logo

Moxie Secures $25.7M Series B to Ignite the Next Wave of Medspa Entrepreneurs

Recently funded · $25.7M Series bMedspa

Get the full Moxie company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Moxie, a pioneering force in the booming medspa industry, is excited to announce that it has raised $25,700,000 in its latest funding round. This milestone investment reinforces our commitment to unlocking entrepreneurial opportunities in aesthetics for individual nurses and aspiring business owners, particularly in communities where medspas are emerging as a vital economic engine. By equipping aesthetic entrepreneurs with a strategic partner, a purpose-built medspa management platform, and unmatched pricing power on injectables, supplies, and more, Moxie empowers professionals to stand toe-to-toe with the largest medspa chains. Today, more than 250 aesthetic entrepreneurs—over 90% of whom are female first-time business owners—have successfully launched, managed, and grown independent medspas under our support. This new funding will accelerate our mission to democratize success in aesthetics by expanding our suite of tools, technology, and services, allowing us to further nurture the business acumen and innovation needed in the competitive medspa landscape. As a healthy, grown-up yet early-stage company operating on a remote-first model, Moxie remains dedicated to providing unmatched resources to drive local economic growth, foster empowered entrepreneurship, and enhance client satisfaction within communities nationwide. The capital infusion will also enable us to further enhance our digital platform, optimize operational efficiencies, and explore new geographical markets, ensuring that even more visionary medspa operators can turn their dreams into thriving realities. To learn more about our journey or explore partnership opportunities, please visit www.joinmoxie.com.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
ElevateAI logo

ElevateAI

$100.0M
2
Ollin Biosciences logo

Ollin Biosciences

United States

$330.0M
3
xCures Inc. logo

xCures Inc.

United States

$46.0M
4
PROPHESEE logo

PROPHESEE

France

$20.0M
5
Isometric logo

Isometric

United Kingdom

$400.0M